Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to determine whether tiotropium inhalation capsules (Spiriva,
Bromuro de Tiotropio), compared to placebo, enhances the improvement in exercise tolerance
seen in patients with chronic obstructive pulmonary disease (COPD) who participate in
pulmonary rehabilitation.